Cannabis processor Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) reported on Wednesday its financial results for the second quarter ended March 31, 2024. The Vancouver-based company said it has achieved 7% sequential and 57% year-over-year revenue growth, hitting a record $3.4 million in net revenue.
Over the past 24 hours, Arbitrum's (CRYPTO: ARB) price has fallen 3.14% to $1.16. This is opposite to its positive trend over the past week where it has experienced a 2.0% gain, moving from $1.14 to its current price.
DKI had Enrique Abeyta from HX Research on to discuss Talen Energy (OTC: TLNE). We’ve been positive on nuclear energy and uranium so his description of the value of Talen’s nuclear plant and high-priced energy sales contract was welcome. Nvidia reported earnings.
Mass retirement of boomers could have major economic impact. Experts anticipate both risks and opportunities from the largest wealth transfer in history.
Surmodics will be acquired by GTCR for $43.00 per share, totaling $627 million. This 41.1% premium reflects Surmodics' advancements in surface modification for medical devices and IVD technologies.
ReShape Lifesciences reported that it gained approval from the United States Patent and Trademark Office for its application entitled, "Intragastric Device (For Treating Obesity)." In the patent filings, the company described the product as a swallowable implant that expands via a balloon in the stomach to induce a feeling of fullness, helping to restrict food intake.
Analysts are predicting a significant shift in the smartphone industry with the introduction of AI-powered "IntelliPhones," and are reiterating Apple as a "top pick."